Sabadell Asset Management’s Boston Scientific BSX Stock Holding History

Sabadell Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9.76M	Buy	182,274 +72,655	+66%	+$3.79M	2.03%	18
2023 Q1	$5.56M	Buy	+109,619	New	+$5.17M	1.18%	33
2022 Q2	–	Sell	-111,074	Closed	-$4.99M	–	150
2022 Q1	$4.99M	Hold	111,074	–	–	0.86%	35
2021 Q4	$4.95M	Hold	111,074	–	–	0.79%	43
2021 Q3	$4.82M	Hold	111,074	–	–	0.83%	40
2021 Q2	$4.75M	Buy	+111,074	New	+$4.67M	0.82%	35

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Sabadell Asset Management's BSX Position: Q2 2023 in Review

Sabadell Asset Management increased its Boston Scientific (BSX) stake by 66% in Q2 2023, buying an estimated $3.79M and bringing the position to 182,274 shares worth $9.76M. The position accounts for 2.03% of the portfolio, ranked #18.

Sabadell Asset Management first reported a position in BSX in Q2 2021 and has held it in 6 quarters since. 1,067 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

Sabadell Asset Management held 182,274 shares of Boston Scientific worth $9.76M as of Q2 2023.
Sabadell Asset Management bought 72,655 Boston Scientific shares in Q2 2023, an estimated $3.79M.
Boston Scientific made up 2.03% of Sabadell Asset Management's portfolio in Q2 2023, its #18 holding.
Sabadell Asset Management first reported a position in Boston Scientific in Q2 2021 and has held it in 6 quarters since.
1,067 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.